Patients identification and patients recruitment for your clinical trials:
Rare diseases are, by definition, seldom, and hard to diagnose. Companies, as yours, willing to run clinical trials on Orphan Drugs, often face problems in recruiting enough patients for their phases II & III clinical studies.
CarthaGenetics® will accelerate your recruitment for such patients through its strong relationships with KOLs, local scientific societies and local patient groups.
With more than 20 years experience in genetics disorders, CarthaGenetics® has developed a very strong expertise in inborn errors of metabolism which have higher incidences in South Mediterranean countries where consanguinity levels are much higher.
For any question, please contact us at: email@example.com